NCT07096102 Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome
| NCT ID | NCT07096102 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meihua Ji |
| Condition | Metabolic Syndrome (MetS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 310 participants |
| Start Date | 2025-08-31 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 310 participants in total. It began in 2025-08-31 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ENRICH study is aimed to Enpower patieNts with metabolic syndrome (Mets) to increase their Risk perception and to acquire health Information necessary for Capability building and promotion of Health information literacy, as well as health outcomes. The purpose of this clinical trial is to evaluate the efficacy of this health information literacy promotion intervention based on Health Empowerment Theory in individuals with metabolic syndrome. The study aims to answer the following questions: Does the intervention improve health information literacy among study participants? Does the intervention lead to better health outcomes, including weight, waist circumference, BMI control, and metabolic health indicators (blood pressure, blood glucose, glycated hemoglobin, and blood lipids)? Participants will: Undergo the intervention program for 6 weeks (face to face and online) and will be assessed regularly to monitor changes in terms of their level of health information literacy and health outcomes.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years old and ≤ 75 years old;； * Patients diagnosed with metabolic syndrome (meeting ≥3 criteria): * Waist circumference ≥ 90 cm (men) / ≥ 85 cm (women) * Fasting glucose ≥ 6.1 mmol/L or OGTT 2h-glucose ≥ 7.8 mmol/L and/or diabetes treatment * Blood pressure ≥ 130/85 mmHg and/or hypertension treatment * Fasting triglycerides (TG) ≥ 1.70 mmol/L * Fasting HDL-C \< 1.04 mmol/L； * Aware of the condition, have basic reading and language communication skills, and voluntarily participate in this study Exclusion Criteria: * Patients with severe liver and kidney dysfunction, cancer, severe cardiovascular and cerebrovascular diseases, gout, etc., which seriously endanger life, have abnormal nutritional status and require special diet; * Pregnant patients； * Patients with a history of mental illness and cognitive impairment； * Those currently participating in other research projects.
Contact & Investigator
Meihua Ji, PhD
PRINCIPAL INVESTIGATOR
Capital Medical University School of nursing
Frequently Asked Questions
Who can join the NCT07096102 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Metabolic Syndrome (MetS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07096102 currently recruiting?
Yes, NCT07096102 is actively recruiting participants. Contact the research team at Mjshouyi@ccmu.edu.cn for enrollment information.
Where is the NCT07096102 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China, Beijing, China, Beijing, China.
Who is sponsoring the NCT07096102 clinical trial?
NCT07096102 is sponsored by Meihua Ji. The principal investigator is Meihua Ji, PhD at Capital Medical University School of nursing. The trial plans to enroll 310 participants.